Clinical Significance of Successful Ablation in Follicular Thyroid Carcinoma
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgaf326 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Haruhiko Yamazaki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama City, Kanagawa 232-0024, Japan. Hauptthemen laut MEDLINE: Adenocarcinoma, Follicular, Thyroid Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Context
Outcomes of postoperative ablation focused on follicular thyroid carcinoma (FTC) have not been fully investigated.
Objective
The purpose of this study is to investigate the clinical characteristics of patients with FTC who received postoperative ablation, the predictive factors for successful ablation, and the association between successful ablation and the clinical outcomes of FTC. Patients The study included 428 patients with FTC (216 in ablation group and 212 in observation group). A multivariate logistic regression model was used to identify factors independently associated with successful ablation.
Results
Patients in the ablation group were significantly older (P < .001), had a higher prevalence of widely invasive–FTC histology (P < .001), had vascular invasion ≥2, and had a higher rate of antithyroglobulin antibody positivity (P = .007) than patients in the observation group. Among the 116 patients with postoperative ablation following diagnostic I-131 scintigraphy, 65 (56%) achieved successful ablation. In the multivariate analysis, the thyroglobulin level at ablation was the only independent predictor of successful ablation (odds ratio 0.952; 95% CI 0.909-0.996; P = .034). Among the ablation group, the 10-year cause-specific survival (CSS) rates of patients with (n = 65) and without successful ablation (n = 151) were 100% and 98.4% (P = .246), respectively. None of the patients with successful ablation died during the follow-up period. The 10-year distant-metastasis–free survival (DMFS) rates of patients with and without successful ablation were 100% and 81.7% (P < .001), respectively. None of the patients with successful ablation experienced distant metastatic recurrence during the follow-up period.
Conclusion
Patients with FTC with successful ablation achieved excellent 10-year CSS and DMFS rates of 100%. Therefore, careful follow-up may be unnecessary for these patients even if they have negative prognostic factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama City, Kanagawa 232-0024, Japan.
- Department of Surgery, Ito Hospital, Tokyo 150-8308, Japan.
- Department of Pathology, Ito Hospital, Tokyo 150-8308, Japan.
- Department of Surgery, Yokohama City University School of Medicine, Yokohama City, Kanagawa 236-0004, Japan.
ORCID-Profile: Haruhiko Yamazaki, Kiminori Sugino
Zitieren
APA
Yamazaki, H., Sugino, K., Katoh, R., Matsuzu, K., Kitagawa, W., Nagahama, M., Saito, A., & Ito, K. (2025). Clinical Significance of Successful Ablation in Follicular Thyroid Carcinoma. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf326
Vancouver
Yamazaki H, Sugino K, Katoh R, Matsuzu K, Kitagawa W, Nagahama M, et al. Clinical Significance of Successful Ablation in Follicular Thyroid Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf326
BibTeX
@article{Yamazaki2025,
author = {Yamazaki, Haruhiko and Sugino, Kiminori and Katoh, Ryohei and Matsuzu, Kenichi and Kitagawa, Wataru and Nagahama, Mitsuji and Saito, Aya and Ito, Koichi},
title = {Clinical Significance of Successful Ablation in Follicular Thyroid Carcinoma},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgaf326}
}
EUVIMED